Global Transforming Growth Factor Beta 1 Market Growth 2021-2026

  • receipt Report ID : 155218
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Transforming Growth Factor Beta 1 will have significant change from previous year. By the most conservative estimates of global Transforming Growth Factor Beta 1 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1280.3 million in 2019. Over the next five years the Transforming Growth Factor Beta 1 market will register a 11.5% CAGR in terms of revenue, the global market size will reach US$ 1980 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Pirfenidone

Galunisertib

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

IPF

Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transforming Growth Factor Beta 1 Consumption 2016-2026

2.1.2 Transforming Growth Factor Beta 1 Consumption CAGR by Region

2.2 Transforming Growth Factor Beta 1 Segment by Type

2.2.1 Pirfenidone

2.2.2 Galunisertib

2.2.3 Others

2.3 Transforming Growth Factor Beta 1 Sales by Type

2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2016-2021)

2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2016-2021)

2.4 Transforming Growth Factor Beta 1 Segment by Application

2.4.1 IPF

2.4.2 Cancer

2.4.3 Others

2.5 Transforming Growth Factor Beta 1 Sales by Application

2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2016-2021)

2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2016-2021)

2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2016-2021)

3 Global Transforming Growth Factor Beta 1 by Company

3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Company

3.1.1 Global Transforming Growth Factor Beta 1 Sales by Company (2019-2021)

3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2021)

3.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company

3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2021)

3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2021)

3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company

3.4 Global Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution

3.4.2 Players Transforming Growth Factor Beta 1 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Transforming Growth Factor Beta 1 by Region

4.1 Global Transforming Growth Factor Beta 1 by Region

4.1.1 Global Transforming Growth Factor Beta 1 Sales by Region

4.1.2 Global Transforming Growth Factor Beta 1 Revenue by Region

4.2 Americas Transforming Growth Factor Beta 1 Sales Growth

4.3 APAC Transforming Growth Factor Beta 1 Sales Growth

4.4 Europe Transforming Growth Factor Beta 1 Sales Growth

4.5 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth

5 Americas

5.1 Americas Transforming Growth Factor Beta 1 Sales by Country

5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2016-2021)

5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)

5.2 Americas Transforming Growth Factor Beta 1 Sales by Type

5.3 Americas Transforming Growth Factor Beta 1 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transforming Growth Factor Beta 1 Sales by Region

6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2016-2021)

6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2016-2021)

6.2 APAC Transforming Growth Factor Beta 1 Sales by Type

6.3 APAC Transforming Growth Factor Beta 1 Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Transforming Growth Factor Beta 1 by Country

7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2021)

7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)

7.2 Europe Transforming Growth Factor Beta 1 Sales by Type

7.3 Europe Transforming Growth Factor Beta 1 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country

8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2021)

8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2021)

8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type

8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Transforming Growth Factor Beta 1 Distributors

10.3 Transforming Growth Factor Beta 1 Customer

11 Global Transforming Growth Factor Beta 1 Market Forecast

11.1 Global Transforming Growth Factor Beta 1 Forecast by Region

11.1.1 Global Transforming Growth Factor Beta 1 Forecast by Regions (2021-2026)

11.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Transforming Growth Factor Beta 1 Forecast by Type

11.7 Global Transforming Growth Factor Beta 1 Forecast by Application

12 Key Players Analysis

12.1 Roche

12.1.1 Roche Roche Company Information

12.1.2 Roche Transforming Growth Factor Beta 1 Product Offered

12.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Roche Main Business Overview

12.1.5 Roche Latest Developments

12.2 Shionogi Ltd

12.2.1 Shionogi Ltd Company Information

12.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered

12.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Shionogi Ltd Main Business Overview

12.2.5 Shionogi Ltd Latest Developments

12.3 Acceleron Pharma Inc

12.3.1 Acceleron Pharma Inc Company Information

12.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered

12.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Acceleron Pharma Inc Main Business Overview

12.3.5 Acceleron Pharma Inc Latest Developments

12.4 Genzyme Corp

12.4.1 Genzyme Corp Company Information

12.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Offered

12.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Genzyme Corp Main Business Overview

12.4.5 Genzyme Corp Latest Developments

12.5 Isarna Therapeutics GmbH

12.5.1 Isarna Therapeutics GmbH Company Information

12.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered

12.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Isarna Therapeutics GmbH Main Business Overview

12.5.5 Isarna Therapeutics GmbH Latest Developments

12.6 Scholar Rock

12.6.1 Scholar Rock Company Information

12.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Offered

12.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Scholar Rock Main Business Overview

12.6.5 Scholar Rock Latest Developments

12.7 Sirnaomics Inc

12.7.1 Sirnaomics Inc Company Information

12.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered

12.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Sirnaomics Inc Main Business Overview

12.7.5 Sirnaomics Inc Latest Developments

12.8 Eli Lilly and Co

12.8.1 Eli Lilly and Co Company Information

12.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered

12.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Eli Lilly and Co Main Business Overview

12.8.5 Eli Lilly and Co Latest Developments

12.9 Formation Biologics Inc

12.9.1 Formation Biologics Inc Company Information

12.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered

12.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Formation Biologics Inc Main Business Overview

12.9.5 Formation Biologics Inc Latest Developments

12.10 Novartis AG

12.10.1 Novartis AG Company Information

12.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Offered

12.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Novartis AG Main Business Overview

12.10.5 Novartis AG Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Transforming Growth Factor Beta 1 Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Pirfenidone

Table 3. Major Players of Galunisertib

Table 4. Major Players of Others

Table 5. Global Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)

Table 6. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

Table 7. Global Transforming Growth Factor Beta 1 Revenue by Type (2016-2021) & ($ million)

Table 8. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2021)

Table 9. Global Transforming Growth Factor Beta 1 Sale Price by Type (2016-2021)

Table 10. Global Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)

Table 11. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Table 12. Global Transforming Growth Factor Beta 1 Value by Application (2016-2021)

Table 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2016-2021)

Table 14. Global Transforming Growth Factor Beta 1 Sale Price by Application (2016-2021)

Table 15. Global Transforming Growth Factor Beta 1 Sales by Company (2019-2021) & (K Units)

Table 16. Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2019-2021)

Table 17. Global Transforming Growth Factor Beta 1 Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2019-2021)

Table 19. Global Transforming Growth Factor Beta 1 Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution and Sales Area

Table 21. Players Transforming Growth Factor Beta 1 Products Offered

Table 22. Transforming Growth Factor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Transforming Growth Factor Beta 1 Sales by Region (2016-2021) (K Units)

Table 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2021)

Table 27. Global Transforming Growth Factor Beta 1 Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2021)

Table 29. Americas Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)

Table 30. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)

Table 31. Americas Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)

Table 33. Americas Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)

Table 34. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

Table 35. Americas Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)

Table 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Table 37. APAC Transforming Growth Factor Beta 1 Sales by Region (2016-2021) & (K Units)

Table 38. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2021)

Table 39. APAC Transforming Growth Factor Beta 1 Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2021)

Table 41. APAC Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)

Table 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

Table 43. APAC Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)

Table 44. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Table 45. Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)

Table 46. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)

Table 47. Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)

Table 49. Europe Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)

Table 50. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

Table 51. Europe Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)

Table 52. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Table 61. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2021-2026) & (K Units)

Table 62. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2021-2026)

Table 63. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 64. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2021-2026)

Table 65. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2021-2026) & (K Units)

Table 66. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2021-2026)

Table 67. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 68. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2021-2026)

Table 69. Roche Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 70. Roche Transforming Growth Factor Beta 1 Product Offered

Table 71. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 72. Roche Main Business

Table 73. Roche Latest Developments

Table 74. Shionogi Ltd Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 75. Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered

Table 76. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 77. Shionogi Ltd Main Business

Table 78. Shionogi Ltd Latest Developments

Table 79. Acceleron Pharma Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 80. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered

Table 81. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 82. Acceleron Pharma Inc Main Business

Table 83. Acceleron Pharma Inc Latest Developments

Table 84. Genzyme Corp Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 85. Genzyme Corp Transforming Growth Factor Beta 1 Product Offered

Table 86. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 87. Genzyme Corp Main Business

Table 88. Genzyme Corp Latest Developments

Table 89. Isarna Therapeutics GmbH Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 90. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered

Table 91. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 92. Isarna Therapeutics GmbH Main Business

Table 93. Isarna Therapeutics GmbH Latest Developments

Table 94. Scholar Rock Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 95. Scholar Rock Transforming Growth Factor Beta 1 Product Offered

Table 96. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 97. Scholar Rock Main Business

Table 98. Scholar Rock Latest Developments

Table 99. Sirnaomics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 100. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered

Table 101. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 102. Sirnaomics Inc Main Business

Table 103. Sirnaomics Inc Latest Developments

Table 104. Eli Lilly and Co Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 105. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered

Table 106. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 107. Eli Lilly and Co Main Business

Table 108. Eli Lilly and Co Latest Developments

Table 109. Formation Biologics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 110. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered

Table 111. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 112. Formation Biologics Inc Main Business

Table 113. Formation Biologics Inc Latest Developments

Table 114. Novartis AG Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 115. Novartis AG Transforming Growth Factor Beta 1 Product Offered

Table 116. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)

Table 117. Novartis AG Main Business

Table 118. Novartis AG Latest Developments

List of Figures

Figure 1. Picture of Transforming Growth Factor Beta 1

Figure 2. Transforming Growth Factor Beta 1 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transforming Growth Factor Beta 1 Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Transforming Growth Factor Beta 1 Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Transforming Growth Factor Beta 1 Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Pirfenidone

Figure 10. Product Picture of Galunisertib

Figure 11. Product Picture of Others

Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020

Figure 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2021)

Figure 14. Transforming Growth Factor Beta 1 Consumed in IPF

Figure 15. Global Transforming Growth Factor Beta 1 Market: IPF (2016-2021) & (K Units)

Figure 16. Transforming Growth Factor Beta 1 Consumed in Cancer

Figure 17. Global Transforming Growth Factor Beta 1 Market: Cancer (2016-2021) & (K Units)

Figure 18. Transforming Growth Factor Beta 1 Consumed in Others

Figure 19. Global Transforming Growth Factor Beta 1 Market: Others (2016-2021) & (K Units)

Figure 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)

Figure 21. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2020

Figure 22. Global Transforming Growth Factor Beta 1 Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company in 2020

Figure 24. Global Transforming Growth Factor Beta 1 Sales Market Share by Regions (2016-2021)

Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2020

Figure 26. Americas Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)

Figure 27. Americas Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)

Figure 28. APAC Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)

Figure 29. APAC Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)

Figure 30. Europe Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)

Figure 31. Europe Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Transforming Growth Factor Beta 1 Sales 2016-2021 (K Units)

Figure 33. Middle East & Africa Transforming Growth Factor Beta 1 Revenue 2016-2021 ($ Millions)

Figure 34. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020

Figure 35. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020

Figure 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020

Figure 37. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020

Figure 38. United States Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region in 2020

Figure 43. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Regions in 2020

Figure 44. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020

Figure 45. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020

Figure 46. China Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020

Figure 53. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020

Figure 54. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020

Figure 55. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020

Figure 56. Germany Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020

Figure 65. Egypt Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Transforming Growth Factor Beta 1 Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles